Partnership & Licensing
Our platform enables validation of existing programs through genomic causal inference modeling, derisking targets and uncovering novel indications aligned with the intended therapeutic intervention. In addition, it supports large-scale screening across all ~23,000 human genes within a therapeutic area of interest to reveal new disease biology and identify novel targets.
Partner with us
Through causal mapping of the genome, we uncover the biological mechanisms underlying disease and enable robust prediction of human efficacy. Our platform is used by biotechnology companies, pharmaceutical organizations, and venture capital firms to de-risk portfolios, identify novel therapeutic targets, and uncover new indications for existing programs.
Our vision is to transform the high-risk biotech business model by enabling a more predictable, data-driven approach to drug discovery. In collaboration with specialized biotechnology firms, pharmaceutical companies and company builders, we leverage the scale of our platform to uncover novel disease biology across multiple therapeutic areas and launch targeted drug discovery programs.
Explore collaboration
